VOLUME 290 (2015) PAGES 22061–22075
A potential conflict of interest was inadvertently omitted. Dr. Tomas A. Prolla is a Scientific Advisor and shareholder with CyteGen, Inc.
VOLUME 290 (2015) PAGES 22061–22075
A potential conflict of interest was inadvertently omitted. Dr. Tomas A. Prolla is a Scientific Advisor and shareholder with CyteGen, Inc.